个人信息

现任职

文章发表情况

第一作者 和/或 通讯作者身份发表SCI论文40余篇,其中影响因子50分以上7篇(JCO(latest IF:50.72)1篇, Ann Oncol(latesIF:51.77)6篇)

主要研究兴趣

• 基于医疗大数据/队列的慢病（癌症为主）基因-环境风险因素分析

• 真实世界数据与临床疗效比较/疾病共诊断研究

• 癌症预后及复发风险预测预警

• 癌症早期诊断及风险预测

主要学术及社会兼职：

• 国家卫生计生委重大新药创制GCP评审专家

• 国家药品监督管理局医疗器械技术审评(CMDE)专家咨询委员会委员

• 中华预防医学会肿瘤预防与控制专业委员会委员

• 中国抗癌协会肿瘤流行病学专业委员会常务委员

• 中国中药协会RWS专业委员会常务委员

• 国家药监局海南真实世界数据研究与评价重点实验室特聘专家

教育经历

工作经历

主要科研项目

1. “十三五”核能开发科研项目子项目：我国核工业部分典型单位从业人员健康状况60年辐射流行病学回顾性调查及前瞻性队列的建立

2. 瑞典国家重大专项课题：基于注册大数据的神经和内分泌相关肿瘤的基因-环境风险因素分析

3. 国际癌症组织（IARC）六国合作课题：CEFALO study

4. 国际癌症组织（IARC）十三国合作课题：INTERPHONE study

5. 瑞典-德国政府合作课题：CUP (Cancer of unknown primary) 基因-环境风险因素研究

6. 真实世界横向课题若干

获奖情况

1. 2015苏州市独墅湖科教创新区（SEID）高端人才集聚工程(科教杰出人才)

2. 2011年国家自费留学生奖学金

近两年第一作者 和/或 通讯作者主要研究成果（*通讯作者）

1. Jiazhen Yao, Xiaohong Chen, Fang Meng, Hanzhong Cao*, Xiaochen Shu*. Combined influence of nutritional and inflammatory status and depressive symptoms on mortality among US cancer survivors: Findings from the NHANES. Brain Behav Immun. 2023 Oct 11:115:109-117. (IF: 15.1, 中科院1区，TOP期刊)

2. Haifeng Zhang, Yinshuang Yao, Xiaoyan Zhong, Fang Meng, Kari Hemminki, Junlan Qiu, Xiaochen Shu*. Association between intake of the n-3 polyunsaturated fatty acid docosahexaenoic acid (n-3 PUFA DHA) and reduced risk of ovarian cancer: A systematic Mendelian Randomization study. Clin Nutr. 2023 Aug;42(8):1379-1388.(IF: 6.3, 中科院1区，TOP期刊)

3. Haifeng Zhang, Junlan Qiu, Fang Meng, Xiaochen Shu*. Insight into the causality between basal metabolic rate and endometrial and ovarian cancers: Analysis utilizing systematic Mendelian randomization and genetic association data from over 331,000 UK biobank participants. Eur J Clin Invest. 2023 Jun;53(6):e13971. (IF: 5.5, 中科院3区)

4. Lin Li, Fang Meng, Dongkui Xu, Lingkai Xu, Junlan Qiu, Xiaochen Shu*. Synergism between the metabolic syndrome components and cancer incidence: results from a prospective nested case-control study based on the China Health and Retirement Longitudinal Study (CHARLS). BMJ Open. 2022 Sep 17;12(9):e061362. (IF: 2.9, 中科院3区)

5. Junlan Qiu, Haifeng Zhang, Dongkui Xu, Lin Li, Lingkai Xu, Yiqing Jiang, Tao Wen, Shun Lu, Fang Meng, Lin Feng, Xiaochen Shu*. Comparing Long-Term Survival Outcomes for Muscle-Invasive Bladder Cancer Patients Who Underwent with Radical Cystectomy and Bladder-Sparing Trimodality Therapy: A Multicentre Cohort Analysis. J Oncol. 2022 May 14:2022:7306198. (IF: 4.3 中科院2区)

代表性第一作者和/或通讯作者研究成果（*通讯作者）

1. 美国临床肿瘤协会杂志

An American Society of Clinical Oncology Journal（latest IF: 50.72）

1. Hemminki K, Ji J, Sundquist J, Shu X*. Familial risks in cancer of unknown primary: tracking the primary sites. J Clin Oncol. 2011 Feb;1;29(4):435-40.

2. 欧洲/日本医学肿瘤协会杂志

An European/Japanese Society of Medical Oncology Journal (latest IF: 51.77)

2. Shu X^#*, Prochazka M^#, Lannering B, Schüz J, Röösli M, Tynes T, Kuehni CE, Andersen TV, Aydin D, Schmidt LS, Poulsen AH, Klaeboe L, Eggen T, Feychting M. Atopic conditions and brain tumor risk in children and adolescents – an international case-control study (CEFALO). Ann Oncol. 2014 March 7 doi:10.1093.

3. Shu X*, Liu H, Ji J, Sundquist K, Försti A, Sundquist J, Hemminki K. Subsequent cancers in patients diagnosed with cancer of unknown primary (CUP): etiological insights? Ann Oncol. 2012 Jan;23(1):269-75.

4. Shu X*, Ji J, Sundquist K, Sundquist J, Hemminki K. Survival in cancer patients with previous hospitalization for sarcoidosis: a Swedish population-based cohort study during 1964 to 2006. Ann Oncol. 2011 Jun;22(6):1427-34.

3. 其它

5. Giorgio Tettamanti^#*, xiaochen shu^#, Maral Adel Fahmideh, Joachim Schuz, Martin Röösli, Tore Tynes, Michael A Grotzer, Christoffer Johansen, Lars Klæboe, Claudia E Kuehni,Birgitta Lannering, Lisbeth Samsø Schmidt, Danielle Vienneau and Maria Feychting. Prenatal and postnatal medical conditions and the risk of brain tumors in children and adolescents: an international multicenter case-control study. Cancer Epidemiology, Biomarkers&Prevention. DOI: 10.1158/1055-9965.EPI-16-0451 Published 13 September 2016 (IF: 3.622)

6. Shu X*, Ahlbom A, Feychting M. Incidence trends of malignant parotid gland tumors in Swedish and Nordic adults 1970 to 2009. Epidemiology. 2012 Sep;23(5):766-7. (IF: 5.866)

7. Shu X*, Ji J, Sundquist J, Sundquist K, Hemminki K. Survival in cancer patients hospitalised for psoriasis: a population-based cohort study in Sweden. Br J Dermatol. 2011 Jul;165(1):129-36. (IF: 4.351)

8. Shu X*, Ji J, Sundquist J, Sundquist K, Hemminki K. Survival in cancer patients hospitalized for inflammatory bowel disease in Sweden. Inflamm Bowel Dis. 2011 Mar;17(3):816-22. (IF: 4.643)

9. Shu X*, Ji J, Sundquist J, Sundquist K, Hemminki K. Cancer risk among patients hospitalized for Type 1 diabetes mellitus: a population-based cohort study in Sweden. Diabet Med. 2010 Jul;27(7):791-7. (IF: 3.182)

10. Shu X*, Ji J, Sundquist J, Sundquist K, Hemminki K. Cancer risk in patients hospitalised for Graves' disease: a population-based cohort study in Sweden. Br J Cancer. 2010 Apr 27;102(9):1397-9.  (IF: 4.346)

语言能力

普通话、英语、瑞典语

（以上内容系教师个人提供）